ArticleCancers2022

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in

Mathias Schneeweiss-Gleixner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.